S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.07 CNY -2.47%
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Operating Margin
Shenzhen Hepalink Pharmaceutical Group Co Ltd

-2.7%
Current
9%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2.7%
=
Operating Profit
-150.1m
/
Revenue
5.6B

Operating Margin Across Competitors

Country CN
Market Cap 13.8B CNY
Operating Margin
-3%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 793.7B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.4T DKK
Operating Margin
45%
Country US
Market Cap 385.5B USD
Operating Margin
28%
Country US
Market Cap 260.6B USD
Operating Margin
29%
Country CH
Market Cap 213.6B CHF
Operating Margin
32%
Country UK
Market Cap 171.2B GBP
Operating Margin
21%
Country CH
Market Cap 183.5B CHF
Operating Margin
29%
Country US
Market Cap 160.4B USD
Operating Margin
22%

Profitability Report

View the profitability report to see the full profitability analysis for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2.7%
=
Operating Profit
-150.1m
/
Revenue
5.6B
What is the Operating Margin of Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Based on Shenzhen Hepalink Pharmaceutical Group Co Ltd's most recent financial statements, the company has Operating Margin of -2.7%.